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Classic lissencephaly is a severe disorder of neocortical neuronal
migration. The lissencephaly spectrum varies from complete or
nearly diffuse agyria to subcortical band heterotopia. The most
commonly mutated gene in patients with classic lissencephaly is
LIS1 (OMIM 601545) [Uyanik et al., 2007; Saillour et al., 2009].
More than 100 LIS1 mutations have are known, with most being
heterozygous large or small exonic deletions or duplications or
truncatingmutations,whereasmissensemutations are less frequent
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2008]. Ten splice site mutations in LIS1 have been reported, but in
most the effects of these mutations at the RNA level have not been
demonstrated.
Here, we describe two unrelated patients with classic lissence-
phaly in whom a recurrent de novomutation at the acceptor splice
site of intron six was identified by targeted-gene sequencing. The
first patient is the first boy of a non-consanguineous couple. Hewas
born after an uneventful pregnancy, with a birth weight of 3240 g
(19th centile), a birth length of 49 cm (12th centile), and anOFC of
33 cm (4th centile). Head control was achieved at 2months but the
ability of sitting independently and standing was delayed at 12 and
15 months, respectively. He walked at the age of 2 years.
Seizures started at 4 years controlled with topiramate and val-
proate. At age of 8 years, his growth parameters were weight 50.1 kg
(>97th centile), height 1.32m (75th centile), and OFC
55 cm . He had normal visual interaction and used approximately
50 words. Hewalked unaided with bilateral genu flessum and varus
deformity. Neurological examination was normal. Brain MRI
showed posterior pachygyria sparing the fronto-temporal
lobes (Fig. 1A–C). The second patient is the first boy of a
non-consanguineous couple. He was born at full term, with a birth
weight of 3670 g (57th centile). Intermittent right nystagmus and
convergent strabismus were noted from the age of 2 months. HeFIG. 1. Representative MRI images of patient 1 at the age of 5 years and
T1 weighted (A and B) and T2 (C and D) images at the level of the basal
and the occipital lobes (A and D), sparing the frontal lobes (A and C), an
weighted images (C and F) show normal corpus callosum, brain stem, anwas brought tomedical attention at 3.5months because of repeated
brief tonic clonic seizures. He was seizure-free from the age of
4 years. At last evaluation at the age of 5.5 years, his growth
parameters were weight 21.3 kg (75th centile), length 113 cm
(50th centile), and OFC 50 cm (10th centile). He had visual
interaction and uttered articulate sounds with his parents. He
could crawl and enjoyed walking a few steps. Neurological exami-
nation showed axial hypotonia and peripheral hypertonia. Brain
MRI showed posterior pachygyria sparing the fronto-temporal
lobes (Fig. 1D–F). In both patients, array CGH was normal. To
identify the underlying cause of the classic lissencephaly in both
patients, we performed targeted-gene sequencing on DNA
extracted from a blood sample, using an NGS panel of 54 genes
involved in cortical malformations. We identified a recurrent
apparently de novo heterozygous mutation at the acceptor splice
site of LIS1 (NM_000430) intron 7: c.569-10T>C (g.2575939T
>C), not reported in public databases, nor in the ExAC database.
All prediction tools (Alamut software using MaxENtSplice splice
score (9.28> 7.49), NNsplice (0.84> 0.69), and ESE finder
(6.31> 5.88), except HSF predicted that this variant reduces the
strength of the consensus acceptor splice site of intron 6. To assess
the functional consequence of the mutation, an RNA study was
performed after extraction and reverse transcription using fibro-
blast cell lines derived from skin biopsies of both patients.5 months (A–C), and patient 2 at the age of 4 months (D–F). Axial
ganglia show pachygyria (thickened cortex) affecting the parietal
d both temporal lobes in coronal section (B and E). Sagittal T1
d cerebellar vermis.
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fragment was observed, an additional shorter PCR product (497
bp) was detected from the patient samples, of which sequencing
showed skipping of exon 7. Skipping induction was quantified and
showed an approximately half decrease of wildtype mRNA abun-
dance compared to control cells. Together, these results support the
view that themutation c.569-10T>Calters the consensus acceptor
splice site of intron 6 Leading to exon seven skipping. Furthermore,
the loss of exon 7 predicted (p.Gly190Alafs3) (Supplemental
Online Fig. S1).
The fraction of cis splicing mutations causing disease is esti-
mated at 15% andmainly comprises mutations known to affect the
canonical splice sites [Krawczak et al., 1992]. However, this pro-
portion is likely to be underestimated and most cis-acting splicing
mutations are likely undiagnosed. It has been proposed that 60%of
mutations that cause disease do so by disrupting splicing [Lopez-
Bigas et al., 2005]. This wide range for the predicted frequency of
splicing mutations reflects our incomplete knowledge of the splic-
ing code and the fact that mRNAs from mutant alleles are rarely
assayed for splicing abnormalities. In fact, one of the limitations of
the systematic analysis of the impact of abnormal splicing as a cause
of disease is the availability of RNA from disease relevant tissues
[Wang and Cooper, 2007]. In classic lissencephaly related to LIS1
mutations, more than 2/3 mutations are nonsense, frameshift
mutations, or deletions. By contrast, splice mutations represent
10/137 mutations reported in HGMD, at least as uncommon as
missense mutations. Although nonsense-mediated mRNA decay
(NMD) is proposed as a key mechanism in the processing of the
LIS1 transcript bearing premature stop codons [Uyanik et al.,
2007], the documentation of this effect in human cells is scarce.
Remarkably, the mutation c.569-10T>C described here was pre-
viously reported in six unrelated patients [Cardoso et al., 2002;
Uyanik et al., 2007] ClinVar (RCV000020304.3) as pathogenic, and
was referenced in dbSNP (rs113994202), without validation. Here,
our data clearly demonstrate that themutation alters the consensus
acceptor splice site of intron 6 Leading to an alternatively spliced
LIS1 mRNA, and the skipping of exon 7 with the formation of a
premature stop codon in exon 8 (p.Gly190Alafs3).
Although previous reports have stressed the clustering of LIS1
mutations in exon 6, only a fewmutations are recurrent, reported in
most cases twice (HGMD).The recurrenceof this intronicmutation
is of importance for clinical practice, although its predictive value
fordisease severity is not demonstrated. For instance, fourout of the
six patients previously reported with the c.569-10T>C mutation
had severe neurological impairment being unable to sit or to
interact, as is the case for the majority of patients with LIS1
Lissencephaly [Cardoso et al., 2002;Uyanik et al., 2007]. In contrast,
both patients reported here, were less severely affected since they are
both able to walk unaided, their seizures were controlled, and their
MRI pattern showed pachygyria sparing the fronto-temporal lobes.
These observations argue for the heterogeneity of the clinical
consequences of the same mutation in LIS1, which has not been
noted previously. Of note, we and others attempted to draw
correlations with the type and the location of mutations [Pilz
et al., 1998; Cardoso et al., 2002; Caspi et al., 2003; Uyanik et al.,
2007; Saillour et al., 2009]. In all reports, themain limitationof such
correlations is the reduced variability among patients with LIS1mutations who exhibit in most cases, mixed agyria–pachygyria,
tetraplegia, and refractory epilepsy. The patients reported here
further demonstrate that the phenotypic variability in patients
with LIS1 related lissencephaly may not be only explained by the
type or the location of the mutation. In conclusion, our data
demonstrate that the recurrent LIS1 intronic mutation disrupt
LIS1 transcript splicing and is responsible for classic lissencephaly
of variable severity. These observations further support that the type
and the location of LIS1mutations is not predictive for the severity
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